semaglutide advertising PRESS The US Food and Drug Administration (FDA) has approved our once-weekly high-dose injectable (7.2 mg) to reduce excess body weight and maintain more weight loss long-term. Learn more in the Novo Nordisk debuts animated Rybelsus

Meals may feel less satisfying, portions may increase, and hunger can return sooner between meals

During the insurers April 30 earnings call, President and Chief Operating Officer Brian Evanko , who is set to become CEO on July 1, said the percentage of clients covering weight management medications has remained relatively stable from 2025 to 2026

That timeline means any study measuring sperm outcomes must run for at least that long to capture a full production cycle, and it means that short-term or rapidly occurring weight loss may temporarily disrupt sperm quality before any benefit is seen

"I trained at the highest level, ate a clean diet, pushed myself, and still, after having kids, my body just wouldnt respond

adults who were receiving either drug between May 2022 and September 2023 and had their weight loss monitored over the course of a year, with subjects matched to reduce the chance of variables like other health conditions influencing the outcome

This sends your metabolism a signal that food scarcity is not permanent, partially resetting some adaptive thermogenesis effects